Magnetic Resonance, Computed Tomography and Nuclear Medicine Market Report Suite | United States | 2010-2016 | MedSuite

  • Year: 2010
  • Scope: 2006-2016
  • Region: United States
  • Pages: 149
  • Published Date: 12/1/2010
  • Type: MedSuite

In 2009, the U.S. market for magnetic resonance (MRI), computed tomography (CT) and nuclear medicine was valued at over $5.1 billion. This market also includes contrast agents and injectors. The market declined in 2009 due to the deficit reduction act, which limited reimbursement for some imaging modalities, and the global economic recession of 2008 to 2009; however, the market is expected to recover by 2016.

This market includes:

Magnetic Resonance Imaging (MRI):

• Low-Field Magnetic Resonance Imaging
• Mid-Field Magnetic Resonance Imaging
• High-Field Magnetic Resonance Imaging
• Open Magnetic Resonance Imaging
• Intraoperative Magnetic Resonance Imaging
Computed Tomography (CT):

• 16/20 Slice Computed Tomography
• 32/40 Slice Computed Tomography
• 64 Slice Computed Tomography
• Ultra Premium Computed Tomography
Nuclear Medicine:

• Ultra Premium Computed Tomography
Contrast Agents and Injectors:

• X-Ray/CT Contrast Agents
• MRI Contrast Agents
• Ultrasound Contrast Agents
• Contrast Injectors

Within the magnetic resonance (MRI), computed tomography (CT) and nuclear medicine markets, companies such as Bracco, Covidien, GE Healthcare, Philips Healthcare and Siemens Healthcare lead the market. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2016, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

The executive summary of this report is also available for purchase.

FREE Sample Report

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology